This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When the day hopefully comes where a vaccine is widely available, we will be relieved of the great stress and uncertainty of this time. 4 Global oncology spending in 2010, 2015, and 2020, by region (in billion U.S. 6 Forbes, ‘Biologic Medicines: The Biggest Driver of Rising DrugPrices’. Touch Oncology.
Single-use bioprocessing technologies enabling more rapid vaccines production [Internet]. Available from: [link] About the author Kai Lipinski, PhD joined Vibalogics, now ReciBioPharm, in 2010 as Head of Cell Culture and Virus Production. million for Hemgenix [AAV5-hFIX-Padua]). Innovation trends in Industrial Biotechnology.
According to the World Health Organization (WHO), two billion people lack access to essential or basic drugs. In 2010, only eight big pharma companies had an access strategy for low- and middle-income countries, but today, 17 of the biggest 20 companies do. Drugpricing and gouging.
September 11, 2023 The Centers for Medicare & Medicaid Services (CMS) recently announced the first 10 drugs selected under its Medicare drugprice “negotiation” plan, authorized by the Inflation Reduction Act (IRA) signed in to law last year. 1] 90% of new cancer drugs are available in the U.S.
… Former President Trump is backing off his support for a controversial drugpricing plan that struck fear into the hearts of pharmaceutical executives during his first term , STAT reports. Meanwhile, we have assembled another menu of tidbits for you to peruse as you start another journey. Your cards and notes are appreciated.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content